Empowered Funds LLC Acquires New Shares in Nutex Health Inc. $NUTX

Empowered Funds LLC purchased a new position in shares of Nutex Health Inc. (NASDAQ:NUTX) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 32,451 shares of the company’s stock, valued at approximately $3,084,000.

A number of other large investors also recently modified their holdings of NUTX. Bank of America Corp DE lifted its holdings in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after buying an additional 2,043 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Nutex Health by 17.9% during the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after acquiring an additional 2,748 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of Nutex Health in the first quarter worth approximately $522,000. JPMorgan Chase & Co. lifted its stake in shares of Nutex Health by 41,430.0% in the second quarter. JPMorgan Chase & Co. now owns 8,306 shares of the company’s stock worth $1,034,000 after acquiring an additional 8,286 shares during the period. Finally, Legal & General Group Plc bought a new stake in Nutex Health in the second quarter valued at approximately $454,000. 5.32% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

NUTX has been the topic of a number of recent analyst reports. Lake Street Capital began coverage on Nutex Health in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price objective on the stock. Zacks Research raised Nutex Health to a “hold” rating in a research note on Monday, June 29th. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Wall Street Zen lowered Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 20th. Finally, B. Riley Financial assumed coverage on Nutex Health in a report on Friday, June 26th. They set a “buy” rating and a $290.00 price target on the stock. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $243.33.

Nutex Health Trading Up 3.2%

Shares of NUTX opened at $157.80 on Wednesday. Nutex Health Inc. has a twelve month low of $77.21 and a twelve month high of $204.00. The stock has a market cap of $1.09 billion, a PE ratio of 12.19 and a beta of 0.24. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. The business’s 50-day moving average price is $155.39 and its 200-day moving average price is $129.03.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.